Compare $CTMX vs $IRWD | Chartloom

Compare

$CTMX vs $IRWD

CytomX Therapeutics Inc · Ironwood Pharmaceuticals Inc

CTMX

CytomX Therapeutics Inc

IRWD

Ironwood Pharmaceuticals Inc

Compare $CTMX vs $IRWD

Comparing CytomX Therapeutics Inc and Ironwood Pharmaceuticals Inc

CTMXCytomX Therapeutics Inc

IRWDIronwood Pharmaceuticals Inc

CTMXCytomX Therapeutics Inc

Market cap

$559M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

32.52x

Rev growth (TTM)

-87.0%

YTD performance

-39.5%

52W performance

-23.7%

FCF yield

-14.8%

IRWDIronwood Pharmaceuticals Inc

Market cap

$629M

P/E (TTM)

4.92x

Forward P/E (NTM)

2.96x

Forward P/S (NTM)

1.30x

Rev growth (TTM)

26.2%

YTD performance

-10.5%

52W performance

141.8%

FCF yield

29.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CTMX

IRWD

Detailed metrics comparison

CTMX

CytomX Therapeutics Inc

IRWD

Ironwood Pharmaceuticals Inc

Market Cap

CTMX$559M

IRWD$629M

Enterprise Value

CTMX$542M

IRWD$935M

Price

CTMX$2.57

IRWD$3.82

P/E Ratio

CTMXN/A

IRWD4.92x

P/S Ratio

CTMX30.57x

IRWD1.62x

EV/Sales

CTMX29.63x

IRWD2.40x

EV/EBITDA

CTMX22.17x

IRWD3.93x

P/B Ratio

CTMX1.85x

IRWD0.85x

P/FCF Ratio

CTMXN/A

IRWD3.39x

EV/FCF

CTMX-6.55x

IRWD5.04x

PEG Ratio

CTMXN/A

IRWDN/A

Forward P/E (NTM)

CTMXN/A

IRWD2.96x

Forward P/S (NTM)

CTMX32.52x

IRWD1.30x

Revenue (TTM)

CTMX$18M

IRWD$389M

Revenue Growth (YoY)

CTMX-87.0%

IRWD26.2%

Forward Rev Growth

CTMX35.7%

IRWD6.4%

Gross Margin (TTM)

CTMX0.0%

IRWD100.0%

Operating Margin (TTM)

CTMX0.0%

IRWD60.2%

EBITDA Margin (TTM)

CTMX-471.6%

IRWD61.1%

Net Margin (TTM)

CTMX-451.6%

IRWD33.4%

FCF Margin (TTM)

CTMX-452.1%

IRWD47.7%

Net Income (TTM)

CTMX$-83M

IRWD$130M

FCF (TTM)

CTMX$-83M

IRWD$186M

EPS (TTM)

CTMX-$0.38

IRWD$0.78

ROE (TTM)

CTMX-3846.0%

IRWD29.3%

ROA (TTM)

CTMX-3033.0%

IRWD34.3%

ROIC (TTM)

CTMX-3846.0%

IRWD17.9%

Cash

CTMX$17M

IRWD$79M

Debt

CTMX$0

IRWD$385M

Net Cash/Debt

CTMX$17M

IRWD$-306M

Current Ratio (TTM)

CTMX9.36x

IRWD6.06x

Quick Ratio (TTM)

CTMX9.25x

IRWD5.84x

Debt/Equity (TTM)

CTMX0.00x

IRWD0.56x

Debt/Assets (TTM)

CTMX0.0%

IRWD0.0%

Interest Coverage (TTM)

CTMXN/A

IRWDN/A

Net Debt/EBITDA (TTM)

CTMX0.00x

IRWD0.00x

Beta

CTMX2.26

IRWD0.22

52W Performance

CTMX-23.7%

IRWD141.8%

YTD Performance

CTMX-39.5%

IRWD-10.5%

% from 52W High

CTMX-68.7%

IRWD-33.9%

% from 52W Low

CTMX5.8%

IRWD170.9%

Asset Turnover (TTM)

CTMX0.07x

IRWD1.03x

FCF Yield (TTM)

CTMX-14.8%

IRWD29.5%

Earnings Yield (TTM)

CTMX-14.8%

IRWD20.7%

Dividend Yield (TTM)

CTMXN/A

IRWDN/A

Rule of 40

CTMX-539.1

IRWD73.8

EV/GP/RG

CTMXN/A

IRWD0.10

Ticker research

View CTMX research View IRWD research

Metric	CTMX CytomX Therapeutics Inc	IRWD Ironwood Pharmaceuticals Inc
Market & Valuation
Market Cap	$559M	$629M
Enterprise Value	$542M	$935M
Price	$2.57	$3.82
P/E Ratio	N/A	4.92x
P/S Ratio	30.57x	1.62x
EV/Sales	29.63x	2.40x
EV/EBITDA	22.17x	3.93x
P/B Ratio	1.85x	0.85x
P/FCF Ratio	N/A	3.39x
EV/FCF	-6.55x	5.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	2.96x
Forward P/S (NTM)	32.52x	1.30x
Revenue & Growth
Revenue (TTM)	$18M	$389M
Revenue Growth (YoY)	-87.0%	26.2%
Forward Rev Growth	35.7%	6.4%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	60.2%
EBITDA Margin (TTM)	-471.6%	61.1%
Net Margin (TTM)	-451.6%	33.4%
FCF Margin (TTM)	-452.1%	47.7%
Net Income (TTM)	$-83M	$130M
FCF (TTM)	$-83M	$186M
EPS (TTM)	-$0.38	$0.78
ROE (TTM)	-3846.0%	29.3%
ROA (TTM)	-3033.0%	34.3%
ROIC (TTM)	-3846.0%	17.9%
Financial Health
Cash	$17M	$79M
Debt	$0	$385M
Net Cash/Debt	$17M	$-306M
Current Ratio (TTM)	9.36x	6.06x
Quick Ratio (TTM)	9.25x	5.84x
Debt/Equity (TTM)	0.00x	0.56x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.26	0.22
52W Performance	-23.7%	141.8%
YTD Performance	-39.5%	-10.5%
% from 52W High	-68.7%	-33.9%
% from 52W Low	5.8%	170.9%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	1.03x
FCF Yield (TTM)	-14.8%	29.5%
Earnings Yield (TTM)	-14.8%	20.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-539.1	73.8
EV/GP/RG	N/A	0.10
Ticker research	View CTMX research	View IRWD research

Valuation

P/E Ratio

IRWD

4.92x

P/S Ratio

IRWD

1.62x

CTMX

30.57x

EV/FCF

CTMX

-6.55x

IRWD

5.04x

Growth & revenue

Revenue Growth TTM

IRWD

26.2%

CTMX

-87.0%

Forward Revenue Growth

CTMX

35.7%

IRWD

6.4%

Profitability & performance

Gross Margin

IRWD

100.0%

CTMX

0.0%

ROE

IRWD

29.3%

CTMX

-3846.0%

FCF Yield %

IRWD

29.5%

CTMX

-14.8%

52-Week Performance

IRWD

141.8%

CTMX

-23.7%

Detailed metrics comparison

CTMX

CytomX Therapeutics Inc

IRWD

Ironwood Pharmaceuticals Inc

Market Cap

CTMX$559M

IRWD$629M

Enterprise Value

CTMX$542M

IRWD$935M

Price

CTMX$2.57

IRWD$3.82

P/E Ratio

CTMXN/A

IRWD4.92x

P/S Ratio

CTMX30.57x

IRWD1.62x

EV/Sales

CTMX29.63x

IRWD2.40x

EV/EBITDA

CTMX22.17x

IRWD3.93x

P/B Ratio

CTMX1.85x

IRWD0.85x

P/FCF Ratio

CTMXN/A

IRWD3.39x

EV/FCF

CTMX-6.55x

IRWD5.04x

PEG Ratio

CTMXN/A

IRWDN/A

Forward P/E (NTM)

CTMXN/A

IRWD2.96x

Forward P/S (NTM)

CTMX32.52x

IRWD1.30x

Revenue (TTM)

CTMX$18M

IRWD$389M

Revenue Growth (YoY)

CTMX-87.0%

IRWD26.2%

Forward Rev Growth

CTMX35.7%

IRWD6.4%

Gross Margin (TTM)

CTMX0.0%

IRWD100.0%

Operating Margin (TTM)

CTMX0.0%

IRWD60.2%

EBITDA Margin (TTM)

CTMX-471.6%

IRWD61.1%

Net Margin (TTM)

CTMX-451.6%

IRWD33.4%

FCF Margin (TTM)

CTMX-452.1%

IRWD47.7%

Net Income (TTM)

CTMX$-83M

IRWD$130M

FCF (TTM)

CTMX$-83M

IRWD$186M

EPS (TTM)

CTMX-$0.38

IRWD$0.78

ROE (TTM)

CTMX-3846.0%

IRWD29.3%

ROA (TTM)

CTMX-3033.0%

IRWD34.3%

ROIC (TTM)

CTMX-3846.0%

IRWD17.9%

Cash

CTMX$17M

IRWD$79M

Debt

CTMX$0

IRWD$385M

Net Cash/Debt

CTMX$17M

IRWD$-306M

Current Ratio (TTM)

CTMX9.36x

IRWD6.06x

Quick Ratio (TTM)

CTMX9.25x

IRWD5.84x

Debt/Equity (TTM)

CTMX0.00x

IRWD0.56x

Debt/Assets (TTM)

CTMX0.0%

IRWD0.0%

Interest Coverage (TTM)

CTMXN/A

IRWDN/A

Net Debt/EBITDA (TTM)

CTMX0.00x

IRWD0.00x

Beta

CTMX2.26

IRWD0.22

52W Performance

CTMX-23.7%

IRWD141.8%

YTD Performance

CTMX-39.5%

IRWD-10.5%

% from 52W High

CTMX-68.7%

IRWD-33.9%

% from 52W Low

CTMX5.8%

IRWD170.9%

Asset Turnover (TTM)

CTMX0.07x

IRWD1.03x

FCF Yield (TTM)

CTMX-14.8%

IRWD29.5%

Earnings Yield (TTM)

CTMX-14.8%

IRWD20.7%

Dividend Yield (TTM)

CTMXN/A

IRWDN/A

Rule of 40

CTMX-539.1

IRWD73.8

EV/GP/RG

CTMXN/A

IRWD0.10

Ticker research

View CTMX research View IRWD research

Metric	CTMX CytomX Therapeutics Inc	IRWD Ironwood Pharmaceuticals Inc
Market & Valuation
Market Cap	$559M	$629M
Enterprise Value	$542M	$935M
Price	$2.57	$3.82
P/E Ratio	N/A	4.92x
P/S Ratio	30.57x	1.62x
EV/Sales	29.63x	2.40x
EV/EBITDA	22.17x	3.93x
P/B Ratio	1.85x	0.85x
P/FCF Ratio	N/A	3.39x
EV/FCF	-6.55x	5.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	2.96x
Forward P/S (NTM)	32.52x	1.30x
Revenue & Growth
Revenue (TTM)	$18M	$389M
Revenue Growth (YoY)	-87.0%	26.2%
Forward Rev Growth	35.7%	6.4%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	60.2%
EBITDA Margin (TTM)	-471.6%	61.1%
Net Margin (TTM)	-451.6%	33.4%
FCF Margin (TTM)	-452.1%	47.7%
Net Income (TTM)	$-83M	$130M
FCF (TTM)	$-83M	$186M
EPS (TTM)	-$0.38	$0.78
ROE (TTM)	-3846.0%	29.3%
ROA (TTM)	-3033.0%	34.3%
ROIC (TTM)	-3846.0%	17.9%
Financial Health
Cash	$17M	$79M
Debt	$0	$385M
Net Cash/Debt	$17M	$-306M
Current Ratio (TTM)	9.36x	6.06x
Quick Ratio (TTM)	9.25x	5.84x
Debt/Equity (TTM)	0.00x	0.56x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.26	0.22
52W Performance	-23.7%	141.8%
YTD Performance	-39.5%	-10.5%
% from 52W High	-68.7%	-33.9%
% from 52W Low	5.8%	170.9%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	1.03x
FCF Yield (TTM)	-14.8%	29.5%
Earnings Yield (TTM)	-14.8%	20.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-539.1	73.8
EV/GP/RG	N/A	0.10
Ticker research	View CTMX research	View IRWD research